This site is intended for health professionals only

At the heart of general practice since 1960

Long acting risperidone cuts admissions

Risperidone long-acting injections can cut hospital admissions for people with schizophrenia, a UK study shows.

Records for 100 patients with schizophrenia who had completed 12 months on risperidone long-acting injections showed a significant reduction in hospital admissions - from 0.62 per person-year to 0.24.

The researchers said the reduction in hospital admissions was a good indicator of a lower chance of relapse – an important finding as 45% of patients in the study were switched to long-acting injections from other medications because of poor compliance.

Adherence to medication is known to be a key factor in relapse prevention, say the authors.

Journal of Psychopharmacology 2008; 22: 128-131

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say